# Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf

> **NCT01562665** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 25 (actual)

## Conditions studied

- Non Small Cells Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01562665
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01562665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01562665, "Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01562665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*